Evolution of Precision Medicine in Non–Small Cell Lung Cancer

home / peer-exchange / evolution-of-precision-medicine-in-non-small-cell-lung-cancer

Experts discuss advancements in the development of targeted agents in oncogene-driven non–small cell lung cancer, highlight the results from key clinical trials presented at the American Society of Clinical Oncology 2021 Annual Meeting, and provide insights on how these findings may support treatment decision making in an era of precision medicine.